90/015,127METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS10,610,125Closed

Status

Request for Reexamination Denied

Filed

Sep 23, 2022

Last Updated

Nov 3, 2022

Examiner

Jean C Witz

Art Unit

3991

Requester

Unknown

Requested By

Third Party

Patent OwnerInferred

Servier Pharmaceuticals LLC

Sector (CPC)

GPhysics & Instruments
G16Bioinformatics
G16HHealthcare Informatics

USPC

436Chemistry: Analytical And Immunological Testing

Reexam History (20 events)

Dec 28, 2022DOCKCase Docketed to Examiner in GAU
Nov 22, 2022NRX.Notice of Reexam Published in Official Gazette
Nov 3, 2022MREXDRX - Mail Ex Parte Request for Reexamination Denied
Oct 7, 2022MRPWPRX - Mail Pilot Waiver Program - Ex Parte Interview Summary
Oct 6, 2022RXTTLRPTTitle Report
Oct 3, 2022MRXNReexamination Formalities Notice Mailed
Oct 3, 2022MRXNReexamination Formalities Notice Mailed
Oct 3, 2022DOCKCase Docketed to Examiner in GAU
Sep 30, 2022RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Sep 30, 2022RXNREQFDNotice of reexamination request filing date
Sep 30, 2022RXNREQAUNotice of assignment of reexamination request
Sep 26, 2022RXLITSRReexam Litigation Search Conducted
Sep 26, 2022PRXRParalegal Reexam Review Complete
Sep 26, 2022FTFIFITF set to NO - revise initial setting
Sep 23, 2022RXOSUB.RReexamination requested by third party requester
Sep 23, 2022RXOSUBReceipt of Original Ex Parte Reexam Request
Sep 23, 2022RXIDS.RReexam - Information Disclosure Statement Filed by Third Party Requester
Sep 23, 2022RXC/SRCertificate of Service
Sep 23, 2022RXAF/DRReexam - Affidavit(s), Declaration(s) and/or Exhibit(s) Filed by Third Party Requester
Sep 23, 2022BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

IPR2022-01423IPRTerminated-Settled

Petitioner

Rigel Pharmaceuticals, Inc.

Petition Filed

Aug 15, 2022

Decision

Jan 6, 2023

Terminated

Jan 6, 2023

Federal Circuit (CAFC)

None found

Terminal Disclaimer

Filed — ApprovedNov 14, 2019

Prosecution History

DateCodeDescription
Nov 19, 2019P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Nov 14, 2019DISTTerminal Disclaimer Filed
Nov 12, 2019P575Paralegal TD Not accepted
Nov 7, 2019DISTTerminal Disclaimer Filed
Nov 5, 2019P575Paralegal TD Not accepted
Nov 5, 2019DISTTerminal Disclaimer Filed

Maintenance Fees

Grant
Apr 7, 2020
3.5-yr
Oct 7, 2023
Paid Oct 9, 2023
7.5-yr
Oct 7, 2027
11.5-yr
Oct 7, 2031
Expiry
Aug 17, 2037

Entity Status

Large Entity

Expires

Aug 17, 2037 (11.4 yr remaining)

Term Adjustment

+101 days (~0.3 yr)

Assignments

2012201320142015201620172018201920202021FiledVALERIA FANTINFRANCESCO G. SALITUROJEFFREY O. SAUNDERSLENNY DANGSTEFAN GROSSSHIN-SAN MICHAEL SUHYUN G. JANGSHENGFANG JINKATHARINE YENAGIOS PHARMACEUTICALS, INC.SERVIER PHARMACEUTICALS LLCSERVIER PHARMACEUTICALS, LLCSERVIER PHARMACEUTICALS, LLC
AssignmentReel/Frame: 050998/0162Recorded: Nov 13, 2019

From

LENNY DANGInventor
Oct 28, 2011
VALERIA FANTINInventor
Oct 27, 2011
STEFAN GROSSInventor
Oct 28, 2011
HYUN G. JANGInventor
Oct 31, 2011
SHENGFANG JINInventor
Oct 31, 2011
FRANCESCO G. SALITUROInventor
Oct 27, 2011
JEFFREY O. SAUNDERSInventor
Oct 27, 2011
SHIN-SAN MICHAEL SUInventor
Oct 28, 2011
KATHARINE YENInventor
Oct 31, 2011

To

AGIOS PHARMACEUTICALS, INC.

AssignmentReel/Frame: 057970/0314Recorded: Oct 28, 2021

From

AGIOS PHARMACEUTICALS, INC.
Mar 29, 2021

To

SERVIER PHARMACEUTICALS LLC

AssignmentReel/Frame: 056224/0921Recorded: May 12, 2021

From

AGIOS PHARMACEUTICALS, INC.
Mar 29, 2021

To

SERVIER PHARMACEUTICALS, LLC

AssignmentReel/Frame: 056179/0417Recorded: May 7, 2021

From

AGIOS PHARMACEUTICALS, INC.
Mar 29, 2021

To

SERVIER PHARMACEUTICALS, LLC